Amgen

Amgen

2026 Med Honors Award · Top Pharmaceutical Innovators

Amgen

Thousand Oaks, CA, USA

Institution Profile

Recognized for Excellence As a Med Honors Top Pharmaceutical Innovator, Amgen has been a pioneer in biotechnology since its founding in 1980. The company focuses on developing therapies for serious illnesses, with significant contributions in oncology and cardiovascular diseases. Amgen's commitment to advancing biologic treatments has led to innovative solutions that have improved patient outcomes worldwide. In oncology, Amgen is dedicated to delivering new therapies to patients with complex cancers. The company is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer. In the realm of cardiovascular diseases, Amgen has set a bold ambition to halve cardiovascular events in the U.S. by 2030, focusing on lowering LDL cholesterol levels to reduce the risk of heart attack and stroke. Amgen's dedication to scientific excellence and patient-centric innovation solidifies its position as a leader in the pharmaceutical industry.

Reviewed by the Med Honors Editorial Team

Profile last updated: July 9, 2026

Med Honors Award

2026 TOP PHARMACEUTICAL INNOVATORS

Amgen

Amgen

Address

Thousand Oaks, CA, USA

Request an Introduction

Tell us what you're looking for. Our team will connect you with the right institution for your needs.

By submitting, you authorize Med Honors to transmit your contact information and message to a qualified institution and service providers used to process this request.

Med Honors

Med Honors is an independent national directory and editorial recognition platform covering physicians, dentists, practices, and healthcare institutions across the United States.

Part of the Expert Honors Network

Expert Honors

Med Honors is an independent directory and editorial recognition platform. Nomination is free and does not influence selection. See our Terms and disclosures for additional information.